PT SANDOZ INDONESIA

PT SANDOZ INDONESIA Company Profile

PT SANDOZ INDONESIA is the Indonesian subsidiary of Sandoz, a global leader in generic pharmaceuticals and biosimilars. Sandoz, formerly a division of Novartis and now an independent company, is dedicated to discovering new ways to improve and extend people's lives. In Indonesia, PT SANDOZ INDONESIA plays a crucial role in providing high-quality, affordable generic medicines and biosimilars, making essential healthcare products accessible to patients across various therapeutic areas. The company is committed to advancing access to medicine and contributing to the health and well-being of the Indonesian population through its diverse product portfolio and operational excellence.

PT SANDOZ INDONESIA operates as a factory.

PT SANDOZ INDONESIA manufactures and/or markets a wide range of pharmaceutical products, including:

* **Generic Medicines:** Covering various therapeutic areas such as cardiovascular, central nervous system, pain management, and anti-infectives.

* **Biosimilars:** Offering biosimilar versions of biologic medicines.

* **Antibiotics:** A range of antibiotics to combat bacterial infections.

* **Oncology Products:** Medications for cancer treatment.

* **Respiratory Products:** Medications for respiratory conditions like asthma and COPD.

* **Dermatological Products:** Medications for skin conditions.

* **Injectables:** Injectable medications for various therapeutic uses.

* **Over-the-Counter (OTC) Products:** A selection of non-prescription medications.